In This Section      
Print This Page

Research Trials: Miscellaneous

TopicStudy NamePrincipal Investigator
Gastroenterology & HepatologyMulticenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety and Tolerability of OCR-002 (ornithine phenylacetate) in Hospitalized Patients with Cirrhosis and Associated Hyperammonemia with an Episode of Hepatic Encephalopathy STOP-HE Study Learn MoreKirti Shetty, M.D.
202-660-5555